Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
出版年份 2017 全文链接
标题
Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors
作者
关键词
-
出版物
PEDIATRIC HEMATOLOGY AND ONCOLOGY
Volume 34, Issue 3, Pages 165-185
出版商
Informa UK Limited
发表日期
2017-06-30
DOI
10.1080/08880018.2017.1330375
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma
- (2016) Marie Regairaz et al. AMERICAN JOURNAL OF PATHOLOGY
- Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma
- (2016) Cecilia Dyberg et al. BMC CANCER
- Factors associated with recurrence and survival length following relapse in patients with neuroblastoma
- (2016) Nermine O Basta et al. BRITISH JOURNAL OF CANCER
- High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients
- (2016) Patrick Y. Kim et al. CANCER LETTERS
- Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway
- (2016) Afzal Sheikh et al. CANCER SCIENCE
- Genetic discoveries and treatment advances in neuroblastoma
- (2016) Rochelle Bagatell et al. CURRENT OPINION IN PEDIATRICS
- Risk stratification and therapeutics of neuroblastoma: the challenges remain
- (2016) Hong Mei et al. World Journal of Pediatrics
- XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis
- (2016) Zhang'e Choo et al. Oncotarget
- Involvement of IL-10 and TGF-β in HLA-E-mediated neuroblastoma migration and invasion
- (2016) Zijun Zhen et al. Oncotarget
- Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma
- (2016) Saurabh Agarwal et al. Oncotarget
- Association of microRNA 21 with Biological Features and Prognosis of Neuroblastoma
- (2016) Yaodong Zhou et al. Cancer Control
- Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
- (2016) Na Hee Lee et al. Cancer Research and Treatment
- Diagnostic Utility of PHOX2B in Primary and Treated Neuroblastoma and in Neuroblastoma Metastatic to the Bone Marrow
- (2015) Jessica L. Hata et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group study
- (2015) L L Wang et al. BRITISH JOURNAL OF CANCER
- Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
- (2015) Kristopher R. Bosse et al. CANCER
- Identification of patient subgroups with markedly disparate rates ofMYCNamplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project
- (2015) Daria Thompson et al. CANCER
- The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients
- (2015) A. Bartolini et al. CANCER RESEARCH
- Telomere maintenance is pivotal for high-risk neuroblastoma
- (2015) Falk Hertwig et al. CELL CYCLE
- High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas
- (2015) Pramila Ramani et al. JOURNAL OF NEURO-ONCOLOGY
- Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors
- (2015) Sho Kurihara et al. JOURNAL OF PEDIATRIC SURGERY
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
- (2015) F Amoroso et al. ONCOGENE
- Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach
- (2015) Kohei Otake et al. PEDIATRIC BLOOD & CANCER
- Neuroblastoma
- (2015) Meredith S. Irwin et al. PEDIATRIC CLINICS OF NORTH AMERICA
- High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas
- (2015) Pramila Ramani et al. VIRCHOWS ARCHIV
- Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
- (2015) S Nicolai et al. Cell Death & Disease
- Identification of GALNT14 as a novel neuroblastoma predisposition gene
- (2015) Marilena De Mariano et al. Oncotarget
- PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions
- (2015) Rosa Gómez-Villafuertes et al. Scientific Reports
- Expression ofFOXP3,CD14, andARG1in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
- (2015) Sara Stigliani et al. Biomed Research International
- Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
- (2015) Giselle L. Saulnier Sholler et al. Cancer Medicine
- Detection of tumorALKstatus in neuroblastoma patients using peripheral blood
- (2015) Valérie Combaret et al. Cancer Medicine
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Chromosome 17/17q gain and unaltered profiles in high resolution array-CGH are prognostically informative in neuroblastoma
- (2014) Jessica Theissen et al. GENES CHROMOSOMES & CANCER
- Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database
- (2014) Daniel A. Morgenstern et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2014) Kieuhoa T. Vo et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical features of ATRX or DAXX mutated neuroblastoma
- (2014) Sho Kurihara et al. JOURNAL OF PEDIATRIC SURGERY
- Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
- (2014) M Czarnecka et al. ONCOGENE
- CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients
- (2014) Ali Rihani et al. PLoS One
- TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival
- (2014) P L Chavali et al. Cell Death & Disease
- Unlikely Suspects Identified in Neuroblastoma Conspiracy
- (2014) R. Bernards Cancer Discovery
- Determination of catecholamines in plasma and urine
- (2013) Eric Grouzmann et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group
- (2013) Larry L. Wang et al. CANCER
- Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study
- (2013) J. Osman et al. Clinical & Translational Oncology
- ALK amplification and protein expression predict inferior prognosis in neuroblastomas
- (2013) Miao Wang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group
- (2013) G. A. Yanik et al. JOURNAL OF NUCLEAR MEDICINE
- Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project
- (2013) Yaël P. Mossé et al. PEDIATRIC BLOOD & CANCER
- Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas
- (2013) N. Ikegaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
- (2012) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors
- (2012) Peter E. Zage et al. CANCER
- VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours
- (2012) Pramila Ramani et al. HISTOPATHOLOGY
- CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway
- (2012) Hervé Sartelet et al. HISTOPATHOLOGY
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
- (2012) Rie Suganuma et al. PEDIATRIC BLOOD & CANCER
- High Anaplastic Lymphoma Kinase Immunohistochemical Staining in Neuroblastoma and Ganglioneuroblastoma Is an Independent Predictor of Poor Outcome
- (2011) Floor A.M. Duijkers et al. AMERICAN JOURNAL OF PATHOLOGY
- Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
- (2011) G Schleiermacher et al. BRITISH JOURNAL OF CANCER
- Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: A report from the INRG project
- (2011) Paola Angelini et al. EUROPEAN JOURNAL OF CANCER
- ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome
- (2011) Franck Bourdeaut et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Prognostic Value of the Stage 4S Metastatic Pattern and Tumor Biology in Patients With Metastatic Neuroblastoma Diagnosed Between Birth and 18 Months of Age
- (2011) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic anaplastic lymphoma kinase (ALK) mutation in neuroblastomas and other pediatric tumors
- (2011) Mi Jung Kwon et al. PATHOLOGY RESEARCH AND PRACTICE
- Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
- (2011) Hervé J. Brisse et al. RADIOLOGY
- The MYCN oncogene and differentiation in neuroblastoma
- (2011) Ulrica K. Westermark et al. SEMINARS IN CANCER BIOLOGY
- Emerging importance of ALK in neuroblastoma
- (2011) Anna M. Azarova et al. SEMINARS IN CANCER BIOLOGY
- Phenotype Restricted Genome-Wide Association Study Using a Gene-Centric Approach Identifies Three Low-Risk Neuroblastoma Susceptibility Loci
- (2011) Lễ B. Nguyễn et al. PLoS Genetics
- NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
- (2010) Michael Hölzel et al. CELL
- Chromosomal and MicroRNA Expression Patterns Reveal Biologically Distinct Subgroups of 11q- Neuroblastoma
- (2010) P. G. Buckley et al. CLINICAL CANCER RESEARCH
- Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
- (2010) S. De Brouwer et al. CLINICAL CANCER RESEARCH
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2010) Julie R. Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Birth weight and risk of neuroblastoma: a meta-analysis
- (2010) T. Harder et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
- (2010) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma
- (2010) Stefano Parodi et al. PEDIATRIC BLOOD & CANCER
- Survival by race among children with extracranial solid tumors in the United States between 1985 and 2005
- (2010) Kelsey A. Johnson et al. PEDIATRIC BLOOD & CANCER
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Aberrant copy numbers of ALK gene is a frequent genetic alteration in neuroblastomas
- (2009) Manish Mani Subramaniam et al. HUMAN PATHOLOGY
- Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma
- (2009) Isabelle Janoueix-Lerosey et al. JOURNAL OF CLINICAL ONCOLOGY
- Poor Survival for Infants WithMYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
- (2009) Adela Canete et al. JOURNAL OF CLINICAL ONCOLOGY
- 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
- (2009) S. E. Sharp et al. JOURNAL OF NUCLEAR MEDICINE
- Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
- (2009) Hilde Brems et al. LANCET ONCOLOGY
- Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma
- (2009) S. A. Vasudevan et al. MOLECULAR CANCER THERAPEUTICS
- High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours
- (2008) Helena Carén et al. BIOCHEMICAL JOURNAL
- High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene
- (2008) Helena Caren et al. BMC GENOMICS
- Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis
- (2008) W.-M. Hsu et al. CLINICAL CANCER RESEARCH
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- Significance ofMYCNAmplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database
- (2008) Rochelle Bagatell et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started